Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
J Cancer Res Clin Oncol. 2020 Jul; 146(7):1711-1723.JC

Abstract

PURPOSE

As a type of cancer with the highest morbidity and mortality, lung squamous cell carcinoma (LUSC) has a very poor prognosis. Long-non-coding RNA (lncRNA) has recently attracted attentions because it can play the role of competing endogenous RNA (ceRNA) to inhibit microRNA (miRNA) functions. In this study, we aimed to find prognosis-related lncRNAs, miRNAs and mRNAs and construct a prognosis-related ceRNA network.

METHODS

The original LUSC RNA-sequencing data and miRNA profiles data were downloaded from the cancer genome atlas (TCGA) database. Differentially expressed lncRNAs, miRNAs and mRNAs were then identified between patients with lymph node metastasis and no lymph node metastasis. Univariate Cox regression analysis was performed to find the survival-associated lncRNAs, miRNAs and mRNAs. Subsequently, prognostic-related ceRNA network was established. By multivariate Cox regression analysis, three lncRNA signatures and three mRNA signatures were developed and used for predicting LUSC patients' survival.

RESULTS

A total of 224 lncRNAs, 160 miRNAs, 913 mRNAs were identified between samples with lymph node metastasis and no lymph node metastasis. Univariate Cox regression analysis showed that, among them, 28 lncRNAs, 8 miRNAs, 105 mRNAs were significantly associated with patients' overall survival time. Further pathway and enrichment analysis suggested that these mRNAs were associated with the regulation of transmembrane transport, regulation of blood circulation, plasma lipoprotein particle organization. Then we constructed a survival-related ceRNA network including 9 lncRNAs, 8 miRNAs and 23 mRNAs. Additionally, a multivariate Cox regression analysis demonstrated that three lncRNAs (AL161431.1, LINC02389, APCDD1L.DT) and three mRNAs (KLK6, SLITRK5, CCDC177) had a significant prognostic value. Risk score indicated that lncRNA signature and mRNA signature could independently predict overall survival in LUSC patients.

CONCLUSION

The current study provided a better understanding of the ceRNA network in the progression of LUSC and laid a theoretical foundation for LUSC prognosis.

Links

Publisher Full Text

Authors+Show Affiliations

Ju Q
Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China. juqiang88@163.com.
Zhao YJ
School of Public Health, Qingdao University, Qingdao, China.
Ma S
Qingdao International Travel Health Center, Qingdao, China.
Li XM
School of Public Health, Qingdao University, Qingdao, China.
Zhang H
School of Public Health, Qingdao University, Qingdao, China.
Zhang SQ
Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Yang YM
Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Yan SX
Department of Blood Transfusion, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.

MeSH

Biomarkers, TumorCarcinoma, Squamous CellCell Line, TumorGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansKaplan-Meier EstimateLung NeoplasmsLymphatic MetastasisMicroRNAsPrognosisRNA InterferenceRNA, Long NoncodingRNA, MessengerROC Curve

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32356177